Peter Grinspoon / Prometheus BooksApr 20, 2023
In 2019, more than 500,000 Americans were arrested for cannabis-related charges, the vast majority for simple possession. Dig deeper ( 8 Min. Read )
Russell Hausfeld / TruthdigMar 23, 2023
This is the concluding feature story in the multi-part Dig series, “The Ecstasy of Agony,” investigating the politics of psychedelic research and its commercialization, with a focus on the historic and present-day links between psychedelia and the military. The first feature explored how veterans were deployed by the Multidisciplinary Association for Psychedelic Studies' (MAPS) as public relations mascots to gain public sympathy for psychedelic pharmaceutical agendas. This piece delves deeper into the lived experiences of veterans recruited by MAPS and explores allegations of manipulation tactics on the part of MAPS and its researchers — allegations that raise serious questions about MAPS' methods and relationships with veterans over the last decade. Dig deeper ( 21 Min. Read )
Russell Hausfeld / TruthdigDec 27, 2022
There is evidence of a serious lack of understanding of consent in the psychedelics industry. Dig deeper ( 11 Min. Read )
Russell Hausfeld / TruthdigDec 7, 2022
The notion of psychedelic treatment as a “reset” for the brain has become exceedingly popular, but the expectations instilled by this type of language can be harmful to patients. Dig deeper ( 3 Min. Read )
Russell Hausfeld / TruthdigDec 6, 2022
A Marine lieutenant colonel uses bad science to advocate for daily LSD supplements for active-duty troops. Dig deeper ( 5 Min. Read )
Russell Hausfeld / TruthdigNov 1, 2022
The emergence of veterans and active duty soldiers as the face of psychedelic research is the result of a controversial political strategy. Dig deeper ( 22 Min. Read )
The Associated PressDec 23, 2019
The 1960s counterculture spiritual leader and early LSD proponent is best known for the 1971 bestseller, "Be Here Now." Dig deeper ( 4 Min. Read )
Eoin Higgins / Common DreamsDec 10, 2019
An expected standoff between Democrats over a drug pricing bill provides a possible preview of larger ideological battles ahead. Dig deeper ( 4 Min. Read )
David Armstrong and Jeff Ernsthausen / ProPublicaSep 10, 2019
Purdue Pharma maintains it was a minor player in the U.S. market for OxyContin. A new analysis of government data suggests otherwise. Dig deeper ( 8 Min. Read )
SEAN MURPHY / The Associated PressAug 26, 2019
In a case likely to affect others, the corporate giant is told to pay $572 million after state says it misstated drug's effects out of greed. Dig deeper ( 3 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, please login or create a user profile.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, upgrade to supporter.